Octapharma
Clovis, CA
Works in Cardiovascular · Dermatology · Genetic & rare · Hematology · Immunology · Infectious disease · Musculoskeletal · Neurology · Oncology · Respiratory
Octapharma is a clinical trial sponsor based in Clovis, CA. It has 11 active clinical trials with 4,590 planned participants, across 10 therapeutic areas. Since 2021 it has completed 28 trials and stopped 7 early. Its FDA record on file shows 11 inspections.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 11 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Octapharma
No warning letter naming Octapharma is on file. FDA has published 11 inspection classifications naming it.
FDA has posted 11 inspection classifications naming Octapharma (11 NAI). The latest inspection ended on 2026-09-16 and was classified NAI (no action indicated). FDA posts a classification after its review, often months after the inspection ended.
Octapharma is lead sponsor of 11 active clinical trials on ClinicalTrials.gov, with 4,590 planned participants, in Cardiovascular, Dermatology, Genetic & rare, Hematology and other areas. Since 2021 it has completed 28 trials and stopped 7 early.
Octapharma is based in Clovis, CA. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Octapharma; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Octapharma.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.